Last reviewed · How we verify
NCT07335185: GRASSROOT Reg
Gravity Stroke System for Recanalization of Large Vessel Occlusion Strokes
NA trial testing Supernova revascularization device in Stroke in 3,000 participants. Not yet recruiting.
31 October 2030
Quick facts
| Lead sponsor | Gravity Medical Technology, INC |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 3,000 |
| Start date | 1 January 2026 |
| Primary completion | 31 October 2030 |
| Estimated completion | 31 December 2030 |
Drugs / interventions tested
- Supernova revascularization device
Conditions studied
- Stroke — all drugs for Stroke →
- Ischemic Stroke — all drugs for Ischemic Stroke →
- Cerebrovascular Disorders — all drugs for Cerebrovascular Disorders →
- Brain Diseases — all drugs for Brain Diseases →
Sponsor
Gravity Medical Technology, INC
Who can join
Eligibility, any sex, with Stroke or Ischemic Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Supernova and Neutron are endovascular mechanical revascularization devices indicated to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing an acute ischemic stroke within 24 hours of symptom onset or from last known well time.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07335185
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Supernova revascularization device
Trials testing the same drug.
- NCT06249776 — Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial · NA · completed
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other Gravity Medical Technology, INC trials
Trials by the same sponsor.
- NCT06249776 — Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07335185 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gravity Medical Technology, INC
- Last refreshed: 13 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07335185.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing